GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioNTech SE (XTER:22UA) » Definitions » 3-Year FCF Growth Rate

BioNTech SE (XTER:22UA) 3-Year FCF Growth Rate : 0.00% (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is BioNTech SE 3-Year FCF Growth Rate?

BioNTech SE's Free Cash Flow per Share for the three months ended in Sep. 2024 was €-2.95.

During the past 12 months, BioNTech SE's average Free Cash Flow per Share Growth Rate was -79.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 8 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of BioNTech SE was 5.60% per year. The lowest was 5.60% per year. And the median was 5.60% per year.


Competitive Comparison of BioNTech SE's 3-Year FCF Growth Rate

For the Biotechnology subindustry, BioNTech SE's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioNTech SE's 3-Year FCF Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioNTech SE's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where BioNTech SE's 3-Year FCF Growth Rate falls into.



BioNTech SE 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


BioNTech SE  (XTER:22UA) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


BioNTech SE 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of BioNTech SE's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


BioNTech SE Business Description

Address
An der Goldgrube 12, Mainz, RP, DEU, D-55131
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.

BioNTech SE Headlines

No Headlines